Concepedia

Michele Melia

MM

Statistics

Publications

86

Citations

8.6K

H-Index

46

Active since

1984

Affiliations

Jaeb Center for Health Research(Current)

Johns Hopkins University

Johns Hopkins Medicine

Northwestern University

Joslin Diabetes Center

Michele Melia is an author at Jaeb Center for Health Research specializing in ophthalmology, medicine, and ocular disease.

ORCID

Publications per year

1984–2025

86

Publications

86

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

John A. Wells, Adam R. Glassman, Allison R. Ayala et al. · Ophthalmology · 2016 · 1K citations · Full text

, , +12

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

Jeffrey G. Gross, Adam R. Glassman, Lee M. Jampol et al. · JAMA · 2015 · 762 citations

, , +14

Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

Jeffrey G. Gross, Adam R. Glassman, Danni Liu et al. · JAMA Ophthalmology · 2018 · 387 citations · Full text

, , +17

Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma I. visual acuity after 3 years COMS report no. 16

Michele Melia, D H Abramson, Daniel M. Albert et al. · Ophthalmology · 2001 · 358 citations

, , +10

Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment

Neil M. Bressler, Wesley T. Beaulieu, Adam R. Glassman et al. · JAMA Ophthalmology · 2018 · 326 citations · Full text

, , +16

1–5 of 86